A major American pharmaceutical company is donating their stockpile of what President Trump has touted as the best treatment drug for COVID-19.
Bayer announced on March 19 that it is joining the U.S. Government’s fight against COVID-19 with a donation of 3 million tablets of the drug Resochin (chloroquine phosphate). Resochin, a product discovered by Bayer in 1934, has long been believed to have “broad-spectrum antiviral properties and effects on the body’s immune response.”
Though not approved currently by the FDA for use in the U.S., Bayer is working with the FDA, HHS, CDC, and the White House to make the anti-malaria drug available to infected patients in America.
President Trump touted chloroquine at a press conference as a possible treatment for coronavirus, saying it will be available “almost immediately.”
FDA Commissioner Steven Hahn said that while chloroquine is already approved for use against malaria, a large-scale clinical trial is required to determine what impact it could have on a patient battling coronavirus.
While the media has been quick to characterize Trump as uninformed, a leading researcher in France posted a breaking news peer-reviewed report of a clinical trial on Mar 19 that has shown “remarkable success.”
Didier Raoult, Director of Marseille’s Mediterranee Infection Foundation said, “Preliminary data comparing chloroquine to other treatments in China showed significant differences.”
Watch the video and see what OAN’s Pearson Sharp says the media continues to focus on rather than any potential cure of the coronavirus.